Home/Filings/4/0000899243-22-038384
4//SEC Filing

Olagunju Peter 4

Accession 0000899243-22-038384

CIK 0001750019other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 8:24 PM ET

Size

8.5 KB

Accession

0000899243-22-038384

Insider Transaction Report

Form 4
Period: 2022-12-09
Olagunju Peter
Chief Technical Officer
Transactions
  • Sale

    Common Stock

    2022-12-12$1.10/sh1,610$1,76625,751 total
  • Sale

    Common Stock

    2022-12-09$1.13/sh1,561$1,76527,361 total
  • Sale

    Common Stock

    2022-12-13$1.06/sh1,659$1,76724,092 total
Holdings
  • Common Stock

    28,922
Footnotes (1)
  • [F1]The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

Entity typeother

Related Parties

1
  • filerCIK 0001875057

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 8:24 PM ET
Size
8.5 KB